Logo-bi
Bioimpacts. 2023;13(3): 181-182. doi: 10.34172/bi.2023.27686
PMID: 37431482        PMCID: PMC10329749

Perspective

The implications of pharmacogenomics in oncology

Jean J. Latimer 1 * ORCID

Cited by CrossRef: 0




As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons